Cargando…
OA21 Ankylosing Spondylitis management with Secukinumab but related Inflammatory bowel disease phenomenon
INTRODUCTION/BACKGROUND: Ankylosing spondylitis is a HLA B27 associated inflammatory spondyloarthropathy. It can be a debilitating disease affecting mobility and quality of life, therefore, effective symptom and disease control is crucial and consists of pharmacological, including biologics, and non...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515824/ http://dx.doi.org/10.1093/rap/rkac066.021 |